1. Home
  2. ENTX vs CPBI Comparison

ENTX vs CPBI Comparison

Compare ENTX & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • CPBI
  • Stock Information
  • Founded
  • ENTX 2010
  • CPBI 2023
  • Country
  • ENTX Israel
  • CPBI United States
  • Employees
  • ENTX 21
  • CPBI N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CPBI
  • Sector
  • ENTX Health Care
  • CPBI
  • Exchange
  • ENTX Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • ENTX 107.3M
  • CPBI 67.1M
  • IPO Year
  • ENTX 2018
  • CPBI N/A
  • Fundamental
  • Price
  • ENTX $2.49
  • CPBI $15.98
  • Analyst Decision
  • ENTX Strong Buy
  • CPBI
  • Analyst Count
  • ENTX 1
  • CPBI 0
  • Target Price
  • ENTX $10.00
  • CPBI N/A
  • AVG Volume (30 Days)
  • ENTX 143.0K
  • CPBI 6.6K
  • Earning Date
  • ENTX 11-07-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • ENTX N/A
  • CPBI N/A
  • EPS Growth
  • ENTX N/A
  • CPBI 0.69
  • EPS
  • ENTX N/A
  • CPBI 0.98
  • Revenue
  • ENTX $166,000.00
  • CPBI $19,464,000.00
  • Revenue This Year
  • ENTX N/A
  • CPBI N/A
  • Revenue Next Year
  • ENTX N/A
  • CPBI N/A
  • P/E Ratio
  • ENTX N/A
  • CPBI $16.23
  • Revenue Growth
  • ENTX 191.23
  • CPBI 9.30
  • 52 Week Low
  • ENTX $1.50
  • CPBI $13.00
  • 52 Week High
  • ENTX $2.95
  • CPBI $16.71
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 64.36
  • CPBI 49.45
  • Support Level
  • ENTX $2.25
  • CPBI $15.90
  • Resistance Level
  • ENTX $2.51
  • CPBI $16.27
  • Average True Range (ATR)
  • ENTX 0.20
  • CPBI 0.06
  • MACD
  • ENTX 0.04
  • CPBI -0.07
  • Stochastic Oscillator
  • ENTX 58.56
  • CPBI 16.58

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.

Share on Social Networks: